US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist
  • 2.270
  • 0.0000.00%
Close May 17 16:00 ET
  • 2.250
  • -0.020-0.88%
Post 17:20 ET
67.71MMarket Cap-904P/E (TTM)

AN2 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
14.07%18.3M
64.77%69.64M
50.81%18.82M
54.46%18.18M
60.66%16.6M
108.76%16.04M
95.89%42.26M
64.29%12.48M
69.79%11.77M
106.74%10.33M
Selling and administrative expenses
-10.19%3.64M
15.79%14.76M
4.62%3.9M
12.24%3.75M
-15.74%3.06M
97.76%4.05M
173.16%12.75M
108.98%3.72M
110.59%3.34M
304.79%3.64M
-General and administrative expense
-10.19%3.64M
15.79%14.76M
4.62%3.9M
12.24%3.75M
-15.74%3.06M
97.76%4.05M
173.16%12.75M
108.98%3.72M
110.59%3.34M
304.79%3.64M
Research and development costs
22.28%14.66M
85.93%54.87M
70.46%14.92M
71.20%14.43M
102.12%13.54M
112.76%11.99M
74.56%29.51M
50.58%8.75M
57.68%8.43M
63.37%6.7M
Operating profit
-14.07%-18.3M
-64.77%-69.64M
-50.81%-18.82M
-54.46%-18.18M
-60.66%-16.6M
-108.76%-16.04M
-95.89%-42.26M
-64.29%-12.48M
-69.79%-11.77M
-106.74%-10.33M
Net non-operating interest income expense
Other net income (expense)
134.50%1.68M
275.42%4.9M
202.37%1.92M
241.76%1.47M
274.18%797K
2,457.14%716K
3,536.84%1.31M
2,781.82%634K
1,297.22%431K
987.50%213K
Other non- operating income (expenses)
134.50%1.68M
275.42%4.9M
202.37%1.92M
241.76%1.47M
274.18%797K
2,457.14%716K
3,536.84%1.31M
2,781.82%634K
1,297.22%431K
987.50%213K
Income before tax
-8.44%-16.62M
-58.05%-64.73M
-42.70%-16.9M
-47.34%-16.71M
-56.17%-15.8M
-100.17%-15.32M
-90.11%-40.96M
-56.95%-11.84M
-63.32%-11.34M
-102.12%-10.12M
Income tax
Net income
-8.44%-16.62M
-58.05%-64.73M
-42.70%-16.9M
-47.34%-16.71M
-56.17%-15.8M
-100.17%-15.32M
-90.11%-40.96M
-56.95%-11.84M
-63.32%-11.34M
-102.12%-10.12M
Net income continuous Operations
-8.44%-16.62M
-58.05%-64.73M
-42.70%-16.9M
-47.34%-16.71M
-56.17%-15.8M
-100.17%-15.32M
-90.11%-40.96M
-56.95%-11.84M
-63.32%-11.34M
-102.12%-10.12M
Minority interest income
Net income attributable to the parent company
-8.44%-16.62M
-58.05%-64.73M
-42.70%-16.9M
-47.34%-16.71M
-56.17%-15.8M
-100.17%-15.32M
-90.11%-40.96M
-56.95%-11.84M
-63.32%-11.34M
-102.12%-10.12M
Preferred stock dividends
-72.06%1.82M
0
Other preferred stock dividends
0
0
Net income attributable to common stockholders
-8.44%-16.62M
-51.33%-64.73M
-42.70%-16.9M
-47.34%-16.71M
-56.17%-15.8M
-61.72%-15.32M
-52.46%-42.78M
-25.05%-11.84M
-27.86%-11.34M
-46.43%-10.12M
Basic earnings per share
29.11%-0.56
1.79%-2.74
6.56%-0.57
-10.17%-0.65
-55.30%-0.81
73.49%-0.79
-80.38%-2.79
-16.85%-0.61
6.54%-0.59
-6.02%-0.5216
Diluted earnings per share
29.11%-0.56
1.79%-2.74
6.56%-0.57
-10.17%-0.65
-55.30%-0.81
73.49%-0.79
-80.38%-2.79
-16.85%-0.61
6.54%-0.59
-6.02%-0.5216
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 14.07%18.3M64.77%69.64M50.81%18.82M54.46%18.18M60.66%16.6M108.76%16.04M95.89%42.26M64.29%12.48M69.79%11.77M106.74%10.33M
Selling and administrative expenses -10.19%3.64M15.79%14.76M4.62%3.9M12.24%3.75M-15.74%3.06M97.76%4.05M173.16%12.75M108.98%3.72M110.59%3.34M304.79%3.64M
-General and administrative expense -10.19%3.64M15.79%14.76M4.62%3.9M12.24%3.75M-15.74%3.06M97.76%4.05M173.16%12.75M108.98%3.72M110.59%3.34M304.79%3.64M
Research and development costs 22.28%14.66M85.93%54.87M70.46%14.92M71.20%14.43M102.12%13.54M112.76%11.99M74.56%29.51M50.58%8.75M57.68%8.43M63.37%6.7M
Operating profit -14.07%-18.3M-64.77%-69.64M-50.81%-18.82M-54.46%-18.18M-60.66%-16.6M-108.76%-16.04M-95.89%-42.26M-64.29%-12.48M-69.79%-11.77M-106.74%-10.33M
Net non-operating interest income expense
Other net income (expense) 134.50%1.68M275.42%4.9M202.37%1.92M241.76%1.47M274.18%797K2,457.14%716K3,536.84%1.31M2,781.82%634K1,297.22%431K987.50%213K
Other non- operating income (expenses) 134.50%1.68M275.42%4.9M202.37%1.92M241.76%1.47M274.18%797K2,457.14%716K3,536.84%1.31M2,781.82%634K1,297.22%431K987.50%213K
Income before tax -8.44%-16.62M-58.05%-64.73M-42.70%-16.9M-47.34%-16.71M-56.17%-15.8M-100.17%-15.32M-90.11%-40.96M-56.95%-11.84M-63.32%-11.34M-102.12%-10.12M
Income tax
Net income -8.44%-16.62M-58.05%-64.73M-42.70%-16.9M-47.34%-16.71M-56.17%-15.8M-100.17%-15.32M-90.11%-40.96M-56.95%-11.84M-63.32%-11.34M-102.12%-10.12M
Net income continuous Operations -8.44%-16.62M-58.05%-64.73M-42.70%-16.9M-47.34%-16.71M-56.17%-15.8M-100.17%-15.32M-90.11%-40.96M-56.95%-11.84M-63.32%-11.34M-102.12%-10.12M
Minority interest income
Net income attributable to the parent company -8.44%-16.62M-58.05%-64.73M-42.70%-16.9M-47.34%-16.71M-56.17%-15.8M-100.17%-15.32M-90.11%-40.96M-56.95%-11.84M-63.32%-11.34M-102.12%-10.12M
Preferred stock dividends -72.06%1.82M0
Other preferred stock dividends 00
Net income attributable to common stockholders -8.44%-16.62M-51.33%-64.73M-42.70%-16.9M-47.34%-16.71M-56.17%-15.8M-61.72%-15.32M-52.46%-42.78M-25.05%-11.84M-27.86%-11.34M-46.43%-10.12M
Basic earnings per share 29.11%-0.561.79%-2.746.56%-0.57-10.17%-0.65-55.30%-0.8173.49%-0.79-80.38%-2.79-16.85%-0.616.54%-0.59-6.02%-0.5216
Diluted earnings per share 29.11%-0.561.79%-2.746.56%-0.57-10.17%-0.65-55.30%-0.8173.49%-0.79-80.38%-2.79-16.85%-0.616.54%-0.59-6.02%-0.5216
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg